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Summary. The contributions of polygenic loci and environ- 
mental factors to femoral bone mineral density (BMD in 
g/cm z) variability were estimated in modified family sets 
consisting of women of child-bearing age. Femoral BMDs 
were measured in 535 women who were members of 137 
family sets consisting minimally of an index, her sister, and 
unrelated female control. The family set could also include 
multiple sisters and first cousins. Women included in these 
family sets were all between 20 and 40 years of age to min- 
imize the cohort effects of maturation and menopause on 
measures of BMD. BMDs were measured at three femoral 
sites using dual photon densitometry. Values were regressed 
on age and Quetelet Index which explained 13-15% of the 
variability in BMD (dependent on site). Subsequent variance 
components analysis on the residuals indicated that unmea- 
sured polygenic loci accounted for substantial additional 
variability: 67% for femoral neck, 58% for Wards triangle, 
and 45% for trochanter. These results suggest that polygenic 
loci account for approximately half of the variability in max- 
imal femoral BMD. 
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bone loss may be influenced by genetic factors associated 
with the level of hormones, perimenopausally, as well as by 
the environmental influences of exposure to exogenous es- 
trogen. 
Estimates of heritability may also vary according to par- 
ticular bone site, potentially because of the nature of the 
interaction of genetic and environmental influences. For ex- 
ample, Dequeker et al. [12] reported a heritability estimate of 
0.75 for the distal radius among 13 pairs of monozygotic and 
dizygotic twins (greater than 25 years of age) whereas the 
estimate of heritability at the spine among the same twin 
pairs was -0 .57 .  Though hip fracture has substantially 
greater social, economic, and mortal outcomes than fracture 
of spine or wrist, relatively few studies have reported a ge- 
netic component for BMD of the femur [3], suggesting the 
need to determine consistency of heritability at multiple 
bone sites. 
The purpose of this study was to estimate for peak fem- 
oral bone mass the proportion of variability explained by 
genetic and environmental factors in a sample of 535 healthy 
women, aged 20-40 years. The results provide insight into 
the contribution made by familial factors to the variability of 
peak femoral BMD. 
Study of factors associated with bone mineral density (BMD 
in g/cm 2) is important to establish profiles of individuals who 
are at risk for osteoporosis and fracture [1]. Osteoporosis is 
thought to be multifactorial in its etiology, involving both 
heredity and environmental contributions [2, 3]. 
Increasingly, researchers hypothesize that a primary de- 
terminant of risk for osteoporosis may be the amount of 
skeletal bone mass acquired in adolescence and early adult- 
hood [4], which is referred to as "peak" or "maximal" bone 
mass. A lower peak bone mass, premenopausally, when 
combined with a substantial bone loss, perimenopausally, 
may place women at a higher risk of osteoporosis. Fre- 
quently, the genetic contribution to osteoporosis has been 
based on the study of bone in aged individuals [5, 6], mixed 
generation groups [7-10], and mixed gender groups [5,11]. 
However, in women the protracted events of menopause and 
associated estrogen replacement may obscure the nature and 
strength of the genetic contribution. Furthermore, maximal 
BMD in early adulthood may have different genetic deter- 
minants than postmenopausal osteoporosis. Postmenopausal 
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Materials and Methods 
Source Population 
This study was designed to describe characteristics of maximal bone 
mass, including its familiality, in adult women, ages 20--40 years. A 
modified family set method was used to identify related and nonre- 
lated participants for study of characteristics that might be familial. 
To that end, we recruited groups that consisted minimally of an 
index woman, her sister, and a nonrelated friend control identified 
by the index, within the specified age range. Female, age-eligible 
first cousins and all age-eligible sisters of the index were asked to 
participate, if available. As ascertainment was independent of fem- 
oral bone mass, assignment as an index case among sisters was 
random and based only on which sister was located by telephone 
first. 
Participants were associated with Tecumseh, Michigan, a rural 
community (n - 10,000) and its immediate environs which have 
served as the location for the Tecumseh Community Health Study 
(TCHS), a total-community study of chronic diseases. Families with 
age-eligible female siblings were identified from the TCHS baseline 
family member roster. Additional participants were recruited by 
presenting the study to organizations and employers with substantial 
female membership, and advertising in the local newspaper. 
Women were excluded from data collection if they were not 
20-40 years, were pregnant or thought they might be pregnant, or 
were cognitively unable to provide informed consent. Women who 
identified their ethnic origin as non-Caucasian were eliminated from 
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data analyses because of small numbers. A total sample of 535 
women in 137 family sets contributed BMD information. There were 
one hundred forty-five unrelated controls, 60 cousins, and 137 sib- 
ships distributed as 96 sibships with 2 sisters, 31 sibships with 3 
sisters, 7 sibships with 4 sisters, 2 sibships with 5 sisters, and 1 
sibship with 7 sisters. Our participation rate was 81% of women 
contacted who lived within 25 miles of Tecumseh. All activities were 
undertaken according to guidelines of the University of Michigan 
Institutional Review Board. 
Measurements 
Table 1. Femoral bone mineral density (g/cm 2) of 535 women con- 
tributing to 137 family sets, and the 282 members of the total sample 
who are not related by blood 
Total sample Unrelated women 
(n = 535) (n = 282) 
Sites (g/cm 2) Mean SD Mean SD 
Femoral neck 0.95 0.12 0.95 0.12 
Wards triangle 0.88 0.14 0.89 0.15 
Trochanter 0.78 0.13 0.79 0.14 
Women were contacted by an interviewer to describe the study 
protocol and to secure consent to participate. A clinic visit was 
scheduled and a self-administered health questionnaire was pro- 
vided. The clinic visit included an additional interview about life- 
style, diet, reproductive history, and health history. BMDs (bone 
mineral content/bone area) of the femoral neck, Wards triangle, and 
trochanter were measured using a Lunar DP3 T M  dual photon den- 
sitometer (Madison, WI) fitted with a Gd 153 source. The location of 
these specific sites has been previously described [13]. The coeffi- 
cient of variation from repeated measures, a measure of precision, 
was 3%. The source was replaced immediately prior to the beginning 
of this study and was not replaced during the 9-month period of data 
collection. Calibration was undertaken before each clinic visit; gen- 
erally, 6--8 women were measured during each clinic visit. A single 
technician conducted all measurements. 
The hip was selected for measurement because fracture at this 
site has substantially greater social, economic, and mortal outcomes 
than fracture of the spine or wrist [14]. Measurement of BMD has 
been reported to be predictive of hip fracture incidence and also 
reflects spinal osteopenia [15, 16]. 
The clinical assessment included measurement of height and 
weight. Height was measured to the nearest millimeter using a 
height board; weight was measured in quarter pounds using a stan- 
dardized balance-beam scale. These values were used to calculate a 
Quetelet Index (weight/height 2) which is weight adjusted for height. 
Variables and Statistical Analyses 
All variables were assessed for the normality of the distribution, and 
descriptive statistics were calculated. Prior to analyses to charac- 
terize potential genetic or familial associations, we examined factors 
that might influence BMD. This examination used only data from 
the 282 women who were neither related by blood nor residence in 
the same household. Factors examined included current and historic 
calcium intake, smoking practices, alcohol use, reproductive char- 
acteristics (i.e., parity, age of menarche, oral contraceptive use), 
and age and measures of body size. Age and Quetelet Index were 
significantly associated with femoral BMD, explaining between 15 
and 19% of the variability in these unrelated participants, depending 
on the site [17]. BMD values were regressed on age and Quetelet 
Index; residual values were used in the analysis of variance and 
variance components analysis. 
One-way analysis of variance was used to assess familiality of 
BMD variability [18]. Familiality describes the influence of family 
membership on a phenotypic characteristic, but does not reflect 
whether phenotypic expression is due to genetic factors, common 
living environment, or both. 
Variance components analysis was used to estimate the propor- 
tion of variability of femoral BMD due to unmeasured genetic and 
environmental factors. Residuals from the regression analysis were 
analyzed under the polygenic model [19]. The model assumed that 
adjusted femoral BMD represented the summed effects of additive 
genes, unmeasured factors shared by members within the same fam- 
ily set, and unmeasured factors specific to each individual (including 
measurement error) to provide a mechanism other than shared genes 
as a possible explanation of the familial aggregation of femoral 
BMD. We speculated that unmeasured factors shared by members 
within the same family might include such things as eating patterns, 
frequency of pregnancy and lactation, and even medical care- 
seeking. 
Following Lange et al. [20, 21], we assumed that after adjustment 
Table 2. Comparison of characteristics of 535 women in the total 
sample and the 282 members of the total sample who are not related 
by blood 
Total sample Unrelated members 
Characteristic Mean SD Mean SD 
Age (years) 31.3 4.8 31.9 5.1 
Height (cm) 163.1 5.8 163.3 5.7 
Weight (kg) 66.4 14.6 67.6 16.2 
Quetelet Index 
(wt/ht 2) 24.9 5.3 25.3 6.0 
for age and Quetelet Index, the femoral BMD measurements for a 
family set followed a multivariate normal distribution. Theoretic 
justification of the assumption of multivariate normality has been 
given elsewhere [21, 22]. Under these assumptions, we partitioned 
the total within-in individual phenotypic variability 0-2 of adjusted 
femoral BMD as a sum of variance components 0 -2 = 0-g2 + O'C2 ~- 
ere 2, where 0-g2 is the additive genetic variance, crc2 is the variance 
of factors shared by members of the same family set, and ~re 2 is the 
variance of factors specific to the individual, including measurement 
error. Under this model, covariances between relatives are 1/2 crg z + 
O'C 2 for sisters, 1/8o'g 2 + O'C 2 for cousins, and 0-c2 for unrelated mem- 
bers of the same family set. 
Under the assumption of independent family sets, the log- 
likelihood of the data set was the sum of the multivariate normal 
log-likelihoods for the individual family sets. Calculation and max- 
imization of these log-likelihoods was carried out using the com- 
puter program FISHER [23]. Maximizing the log-likelihood permit- 
ted maximum likelihood parameter estimation; it also provided a 
means for hypothesis testing of nested models using the likelihood 
ratio criterion, and for maximum likelihood comparison of non- 
nested models. We constrained the variance components to be pos- 
itive because there is no evidence of familial disaggregation in BMD. 
Results 
The  m e a n  and  s t andard  dev ia t ion  of  the  normal ly  d i s t r ibu ted  
femora l  B M D s  for  the  neck ,  W a r d s  t r iangle,  and  t r o c h a n t e r  
are s h o w n  in Table  1. These  va lues  are sl ightly lower  ( - 3 %  
for femora l  neck  and  W a r d s  t r iangle;  2% for  t r ochan t e r )  t han  
those  r epor ted  by  Mazess  and  B a r d e n  [24] w h o  used  the  
same i n s t rumen ta t i on  to cha rac t e r i ze  w o m e n  of  the  s ame  age 
group.  Tab le  2 d e s c r i b e s  the  phys i ca l  c h a r a c t e r i s t i c s  of  
w o m e n  in the  sample  including height ,  weight ,  Que te le t  In-  
dex,  and  age. 
A one -way  analys is  of  va r i ance  of  the  u n a d j u s t e d  femora l  
B M D  values  sugges ted  highly s ignif icant  familial  aggrega t ion  
and  were  as fol lows:  femora l  neck  (R 2 = 0.65, P < 0.0001); 
Wards  t r iangle (R 2 = 0.64, P < 0.0001); and  t r o c h a n t e r  (R z 
= 0.66, P < 0.0001). The  p ropor t ion  of  va r i a t ion  exp la ined  
by  s ibships  for  va lues ,  ad jus ted  for  age and  Quete le t  Index ,  
for  femora l  B M D  were  as fol lows:  f emora l  n e c k  (R 2 -- 0.68, 
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Table 3. Variance components estimates (with standard errors in parentheses) for bone mineral density of three locations of the femoral head, 
following adjustment for age and Quetelet Index, with likelihood ratio statistics ( -  2 logA) to compare possible models to the complete model 
Individual-specific Additive Family set 
Site environment component genetic component environment component - 2  logA 
Femoral neck 
Model 1 0.01212 
(0.00074) 
Model 2 0.00259 0.00974 
(0.00159) (0.00208) 
Model 3 0.00788 0.00424 
(0.00075) (0.00086) 
Model 4 0.00259 0.00974 0.00000 
(0.00159) (0.00208) *** 
Trochanter 
Model 1 0.01410 
(O.OOO86) 
Model 2 0.00486 0.00931 
(0.00147) (0.00182) 
Model 3 0.00933 0.00482 
(0.00089) (0.00010) 
Model 4 0.00570 0.00743 0.00110 
(0. O0159) (0.00208) (0.00320) 
Wards triangle 
Model 1 0.01724 
(O.00106) 
Model 2 0.00571 0.01157 
(0.00184) (0.00228) 
Model 3 0.01140 0.00580 
(0.00108) (0.00121) 
Model 4 0.00571 0.01157 0.00000 













*** Parameter bounded at zero 
P < 0.0001); Wards triangle (R 2 = 0.67, P < 0.0001); and 
trochanter (R 2 = 0.69, P < 0.0001). 
Variance components analysis was used to characterize 
the summed effects of unmeasured genes and unmeasured 
environmental factors in addition to that already attributed 
to body size, expressed as Quetelet Index and age. Residuals 
from regression analysis of BMD with age and Quetelet In- 
dex were used under the assumption that age and Quetelet 
Index were known concomitants and that adjustment for 
them allowed for the description of polygenic factors for 
BMD in excess of body size. Results of the analysis for the 
age and Quetelet-adjusted femoral BMDs, including the pa- 
rameter estimates and their standard errors, are shown in 
Table 3. The variance shown for Model 1 is segmented into 
separate components in Models 2, 3, and 4. Model 4 is the 
complete model reflecting the sum of the variance compo- 
nents for which partitioning was undertaken. The likelihood 
ratio statistics compare individual component models to the 
complete model to test the hypothesis of no difference be- 
tween models. 
The estimates shown in Table 3 suggest the presence of a 
significant genetic effect for all three sites, although shared 
environment cannot be dismissed as an explanation for tro- 
chanter and Wards triangle. At the femoral neck site, the 
most parsimonious model included genes and the unmea- 
sured component specific to the individual. This model at- 
tributed 79% of the variability in regressed BMD, adjusted 
for age and body size, to genes (79% = 0.00974/(0.00259 + 
0.00974)). For Wards triangle, this genetic model attributed 
67% of the variability in adjusted BMD to genes. For the 
trochanter, the complete model attributed 52% of variability 
to genes and 7% of the variability to an unmeasured factor 
shared by members of a family set; the genetic model attrib- 
uted 66% of the variability. 
Table 4 summarizes the proportion of variability ex- 
plained by measured concomitants, unmeasured genes, and 
unmeasured factors shared by members of a family set. At 
the femoral neck, age and body size, the measured concom- 
itants, accounted for 15% of the variability in BMD, leaving 
85% of variability unexplained. Under the variance compo- 
nents analysis, unmeasured genes accounted for an addi- 
tional 67% (85% x 79%) of the variability. Similarly, in mod- 
els for the trochanter and Wards triangle, genes accounted 
for an additional 45% and 58% of variability, respectively. 
The three proximal femur sites are interrelated such that 
quantified variability associated with genes is not indepen- 
dent. 
Discussion 
This partitioning of the variability of peak femoral BMD sug- 
gests that substantial variation may be explained by unmea- 
sured genes. Prior to considering familial factors, measured 
concomitants (age and Quetelet Index) explained 13-15% of 
the variability. Unmeasured genes and unmeasured environ- 
mental factors shared by members of a family set explained 
an additional 51-67% of the variability in peak femoral 
BMD, depending on femoral site. 
The values reported appear to be consistent with those of 
Pocock et al. [25] who studied femoral BMD in 32 female and 
6 male monozygotic twin pairs, as well as 26 female and 1 
male dizygotic twin pairs (aged 24-75 years). The genetic 
component would have been greater had we not already ad- 
justed for the variability attributable to body size (data not 
shown), a characteristic previously observed to have a ge- 
netic component [26, 27]. 
Establishing that genes play a role in determining femoral 
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Table 4. Sources of variability in peak femoral bone mineral densi- 





Femoral neck Age, Quetelet Index 15 
Unmeasured genes 67 
Unmeasured family set 
environment 0 
Unexplained variance 18 
Trochanter Age, Quetelet Index 14 
Unmeasured genes 45 
Unmeasured family set 
environment 6 
Unexplained variance 35 
Wards triangle Age, Quetelet Index 13 
Unmeasured genes 58 
Unmeasured family set 
environment 0 
Unexplained variance 29 
BMD in women of child-bearing age is an important step in 
characterizing genetic etiology of osteoporosis. Previous 
studies of the role of genetics in BMD have typically focused 
on samples of individuals who were aged [5, 6] or mixed 
generations [7-10]. The interpretation of a genetic contribu- 
tion to peak BMD in these studies may have been obscured 
by the multiple lifestyle factors that influence the estimate of 
BMD. In women particularly, the protracted onset of meno- 
pause and treatment of its symptomatology may obscure im- 
portant relationships [8]. However, studies of more aged 
populations may help to establish a role for an additional 
genetic contribution of menopause to BMD. 
Previous evaluations of a genetic contribution to osteo- 
porosis have used estimates of bone mineral content from 
the appendicular skeleton, usually the distal radius, in stud- 
ies of twins [5, 6, 11, 12], mother/daughter pairs [8, 9, 28], 
and racial differences [29, 30]. However, it is recognized that 
hip fractures are the predominant events of interest in terms 
of increased mortality and health care costs [14]. Fractures 
at the hip may be associated with lifestyle risks different than 
risks associated with the distal radius. For example, weight 
bearing is likely to contribute more strongly to the level of 
femoral BMD and influence the phenotypic expression of the 
heritable contribution. Thus, it is important to determine the 
consistency of heritable components at several skeletal sites. 
Recent studies using parent/offspring correlations [10, 31, 
32] and relatives of osteoporotic patients [33] suggest the 
importance of a genetic role in peak bone density. Because 
the studies are characterized by small samples of volunteers, 
confirmation with a larger sample using a community-based 
sampling frame is important. 
Variance components analysis can be helpful in distin- 
guishing whether the familiality of femoral BMD are more 
likely to have a genetic or environmental component. Even 
when such a distinction is made, the magnitude may not be 
definitive. Though the genetic model has a substantially 
greater likelihood than the shared family set environmental 
model for the femoral neck, the shared family environment 
model cannot be dismissed as an explanation for the data at 
the other two sites. This study suggests that consideration of 
genetic influence is important. Having established a substan- 
tial role for gene(s) in peak femoral bone mass, the next step 
would be to begin a more systematic study of genetic etiol- 
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ogy. For example, no study has identified that healthy 
women with low peak BMD have a genetic profile different 
from that of women with average peak BMD; this is an area 
for future exploration. Additionally, we have shown that low 
estrogen levels are significantly associated with low pre- 
menopausal BMD [34]. It would be important to determine if 
bone mass heritability is similar in premenopausal women 
with higher and lower estrogen levels. 
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